Page 14 - Cell Host News Today

Researchers at NYU Grossman School of Medicine and Janssen Biotech, Inc. have shown in early tests that a bioengineered drug candidate can counter infection with Staphylococcus aureus – a bacterial species widely resistant to antibiotics and a major cause of death in hospitalized patients.

Ever since chronic fatigue syndrome — or myalgic encephalomyelitis — was identified in the 1980s, its cause has been a mystery.

Researchers explored commensalism and pathogenesis relationships in the human mycobiome.

The researchers provide important insights into the cross-feeding mechanisms of nutrients in the gut microbiome and their impacts on host health.

MIT researchers find Staphylococcus aureus can rapidly evolve within a single person’s microbiome. In people with eczema, S. aureus tends to evolve to a variant with a mutation in a specific gene that helps it grow faster on the skin.

Q: I gave birth with a C-section recently and have heard that when a baby doesn't pass through the vaginal canal, it is deprived of essential microbes that build a healthy gut. If that's true, how can I make up for that so my child is as healthy as possible? —Donna R., Richmond, Virginia

A genetically modified beneficial strain of bacteria blocked intestinal inflammation in a preclinical model of inflammatory bowel disease.

DR MARTIN SCURR: At least one study has shown that burning mouth has been linked to Covid; but its very rare and tends to occur during or immediately after the infection.

Humans are colonized with thousands of bacterial strains. Researchers are now focused on genetically modifying such bacteria to enhance their intrinsic therapeutic properties.

MRSA skin infections could become worse by antibiotics